プラスミノーゲンアクチベーターインヒビター1
関連文献

“[Type 1 plasminogen activator inhibitor: its role in biological reactions]”. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology 32 (5):  487–489. (May 1991). PMID 1870265.
“Plasminogen activator inhibitor 1: physiological and pathophysiological roles”. News in Physiological Sciences 17 (2):  56–61. (April 2002). doi:10.1152/nips.01369.2001. PMID 11909993.
“Plasminogen activator inhibitor-1 and the kidney”. American Journal of Physiology. Renal Physiology 283 (2):  F209–F220. (August 2002). doi:10.1152/ajprenal.00032.2002. PMID 12110504.
“Association between platelet activation and fibrinolysis in acute stroke patients”. Neuroscience Letters 384 (3):  305–309. (August 2005). doi:10.1016/j.neulet.2005.04.090. PMID 15916851.
“Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn”. Biological Chemistry 383 (7–8):  1143–1149. (2003). doi:10.1515/BC.2002.125. PMID 12437099.
“The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors”. Thrombosis and Haemostasis 91 (3):  425–437. (March 2004). doi:10.1160/TH03-12-0764. PMID 14983217.
“Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis”. Thrombosis and Haemostasis 91 (3):  438–449. (March 2004). doi:10.1160/TH03-12-0784. PMID 14983218.
“Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer”. Thrombosis and Haemostasis 91 (3):  450–456. (March 2004). doi:10.1160/TH03-12-0798. PMID 14983219.
“Plasminogen activator inhibitor type 1: the two faces of the same coin”. Current Opinion in Nephrology and Hypertension 13 (1):  39–44. (January 2004). doi:10.1097/00041552-200401000-00006. PMID 15090858.
“Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk”. Thrombosis and Haemostasis 91 (5):  861–872. (May 2004). doi:10.1160/TH03-08-0546. PMID 15116245.
“Pleiotropic functions of plasminogen activator inhibitor-1”. Journal of Thrombosis and Haemostasis 3 (1):  35–45. (January 2005). doi:10.1111/j.1538-7836.2004.00827.x. PMID 15634264.
“Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease”. Current Opinion in Pharmacology 5 (2):  149–154. (April 2005). doi:10.1016/j.coph.2005.01.007. PMID 15780823.
“Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease”. Thrombosis and Haemostasis 93 (4):  631–640. (April 2005). doi:10.1160/TH05-01-0033. PMID 15841306.
“[Role of PAI-1 in gynaecological malignancies]”. Zentralblatt für Gynakologie 127 (3):  125–131. (June 2005). doi:10.1055/s-2005-836407. PMID 15915389.
“Plasminogen activator inhibitor type 1 gene polymorphism and sepsis”. Clinical Infectious Diseases 41 (Suppl 7):  S453–S458. (November 2005). doi:10.1086/431996. PMID 16237647.
“Plasminogen activator inhibitor-1, adipose tissue and insulin resistance”. Current Opinion in Lipidology 18 (3):  240–245. (June 2007). doi:10.1097/MOL.0b013e32814e6d29. PMID 17495595.
線維素溶解過程の模式図。青い矢印は刺激、赤い矢印は阻害を表している。